Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | PHD finger protein 8 | Starlite/ChEMBL | References |
Homo sapiens | lysine (K)-specific demethylase 2A | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Candida albicans | similar to S. cerevisiae YER051W | Get druggable targets OG5_129555 | All targets in OG5_129555 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_129555 | All targets in OG5_129555 |
Candida albicans | similar to S. cerevisiae YER051W | Get druggable targets OG5_129555 | All targets in OG5_129555 |
Brugia malayi | jmjC domain containing protein | Get druggable targets OG5_129555 | All targets in OG5_129555 |
Brugia malayi | jmjC domain containing protein | Get druggable targets OG5_129555 | All targets in OG5_129555 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | jmjC domain containing protein | 0.0074 | 0.4122 | 1 |
Echinococcus multilocularis | cpg binding protein | 0.0065 | 0.1432 | 0.5 |
Brugia malayi | jmjC domain containing protein | 0.0074 | 0.4122 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0065 | 0.1432 | 1 |
Onchocerca volvulus | 0.0061 | 0 | 0.5 | |
Echinococcus granulosus | cpg binding protein | 0.0065 | 0.1432 | 0.5 |
Schistosoma mansoni | cpg binding protein | 0.0065 | 0.1432 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 3.7 uM | Inhibition of human KDM2A expressed in Escherichia coli using methyl lysine peptide substrate by AlphaScreen assay | ChEMBL. | 22724510 |
IC50 (binding) | = 11.5 uM | Inhibition of human PHF8 expressed in Escherichia coli using methyl lysine peptide substrate by AlphaScreen assay | ChEMBL. | 22724510 |
IC50 (binding) | > 100 uM | Inhibition of human BBOX1 by fluorescence based assay | ChEMBL. | 22724510 |
IC50 (binding) | > 100 uM | Inhibition of human PHD2 expressed in Escherichia coli by fluorescence based assay | ChEMBL. | 22724510 |
IC50 (binding) | > 100 uM | Inhibition of human FIH expressed in Escherichia coli by MALDI assay | ChEMBL. | 22724510 |
IC50 (binding) | > 100 uM | Inhibition of human KDM6B catalytic domain expressed in Escherichia coli using methyl lysine peptide substrate by AlphaScreen assay | ChEMBL. | 22724510 |
IC50 (binding) | > 100 uM | Inhibition of human KDM5C catalytic domain expressed in Sf9 cells using methyl lysine peptide substrate by AlphaScreen assay | ChEMBL. | 22724510 |
IC50 (binding) | > 100 uM | Inhibition of human KDM4E expressed in Escherichia coli using methyl lysine peptide substrate by AlphaScreen assay | ChEMBL. | 22724510 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.